Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections-Reference-Cited by-同舟云学术

Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections

Published:2016-02 Issue:2 Volume:47 Page:124-131
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Lamoureux Fabien,Duflot Thomas,Woillard Jean-Baptiste,Metsu David,Pereira Tony,Compagnon Patricia,Morisse-Pradier Hélène,El Kholy Mona,Thiberville Luc,Stojanova Jana,Thuillez Christian

Publisher

Elsevier BV

Reference30 articles.

1. CYP2C19 polymorphisms and therapeutic drug monitoring of voriconazole: are we ready for clinical implementation of pharmacogenomics?;Owusu Obeng;Pharmacotherapy,2014

2. Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations;Smith;Ther Drug Monit,2008

3. Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype;Scholz;Br J Clin Pharmacol,2009

4. Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing;Dolton;J Antimicrob Chemother,2014

5. Antifungal therapeutic drug monitoring: established and emerging indications;Andes;Antimicrob Agents Chemother,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient With Probable Invasive Pulmonary Aspergillosis and Idiopathic Bilateral Chylothorax With Chylopericardium May Experience Unachievable Therapeutic Voriconazole Serum Levels;Therapeutic Drug Monitoring;2025-04-28

2. Pharmacokinetic novelties of isavuconazole. Use in special situations;Revista Iberoamericana de Micología;2025-01

3. Clinical utility of pharmacogenomic testing for patients with coccidioidal meningitis;Medical Mycology;2024-11-20

4. Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review;Frontiers in Pharmacology;2024-11-07

5. WHICH TOOL IS THE BEST GUIDE OPTIMIZE THE VORICONAZOLE DOSAGE: THERAPEUTIC DRUG MONITORING OR CYTOCHROME P450 POLYMORPHISM?;Sağlık Bilimleri Dergisi;2024-07-25